Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase 3, Randomized, Controlled Trials

被引：0

作者：

Gladman, Dafna ^{[1
]}

Mease, Phillip ^{[2
,3
]}

Kavanaugh, Arthur ^{[4
]}

Adebajo, Adewale ^{[5
]}

Gomez-Reino, Juan ^{[6
]}

Wollenhaupt, Juergen ^{[7
]}

Cutolo, Maurizio ^{[8
]}

Schett, Georg ^{[9
]}

Lespessailles, Eric ^{[10
]}

Shah, Kamal ^{[11
]}

Hu, ChiaChi ^{[11
]}

Stevens, Randall ^{[11
]}

Edwards, Christopher ^{[12
]}

Birbara, Charles ^{[13
]}

机构：

[1] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada

[2] Swedish Med Ctr, Seattle, WA USA

[3] Univ Washington, Sch Med, Seattle, WA USA

[4] Univ Calif San Diego, San Diego, CA 92103 USA

[5] Univ Sheffield, Sheffield, S Yorkshire, England

[6] Hosp Clin Univ, Santiago, Chile

[7] Schon Klin Hamburg Eilbek, Hamburg, Germany

[8] Univ Genoa, Genoa, Italy

[9] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany

[10] Univ Orleans, Orleans, France

[11] Celgene Corp, Warren, MI USA

[12] Southampton Univ Hosp, Southampton, Hants, England

[13] Univ Massachusetts, Sch Med, Worcester, MA USA

来源：

JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1449 / 1449

页数：1

共 50 条

[1] Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-Term (52-Week) Improvements In Enthesitis and Dactylitis In Patients With Psoriatic Arthritis: Pooled Results From Three Phase 3, Randomized, Controlled Trials
Gladman, Dafna D.
Mease, Philip J.
Kavanaugh, Arthur
Adebajo, Adewale O.
Gomez-Reino, Juan J.
Wollenhaupt, Juergen
Cutolo, Maurizio
Schett, Georg
Lespessailles, Eric
Shah, Kamal
Hu, ChiaChi
Stevens, Randall M.
Edwards, Christopher J.
Birbara, Charles A.
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S347 - S347
[2] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial
Edwards, Christopher J.
Aelion, Jacob A.
Adebajo, Adewale O.
Kivitz, Alan
Bird, Paul
Hu, ChiaChi
Stevens, Randall M.
Wells, Alvin
[J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S694 - S695
[3] APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (52-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE PALACE 4 PHASE 3, RANDOMIZED, CONTROLLED TRIAL
Edwards, C.
Wells, A.
Adebajo, A.
Kivitz, A.
Bird, P.
Shah, K.
Hu, C.
Stevens, R. M.
Aelion, J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 735 - 735
[4] Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvements in enthesitis and dactylitis in patients with psoriatic arthritis: Pooled results from three phase 3, randomized, controlled trials
Gladman, Dafna
Kavanaugh, Arthur
Adebajo, Adewale
Gomez-Reino, Juan
Wollenhaupt, Juergen
Cutolo, Maurizio
Schett, Georg
Lespessailles, Eric
McIlraith, Melissa
Hu, ChiaChi
Edwards, Christopher
Birbara, Charles
Mease, Philip
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S32 - S32
[5] APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE 3, RANDOMIZED, CONTROLLED TRIALS
Gladman, D.
Kavanaugh, A.
Adebajo, A.
Gomez-Reino, J.
Wollenhaupt, J.
Cutolo, M.
Schett, G.
Lespessailles, E.
McIlraith, M.
Hu, C.
Edwards, C.
Birbara, C.
Mease, P.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 133 - 134
[6] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials
Gladman, Dafna
Kavanaugh, Arthur
Adebajo, Adewale
Gomez-Reino, Juan
Wollenhaupt, Juergen
Cutolo, Maurizio
Schett, Georg
Lespessailles, Eric
McIlraith, Melissa
Hu, ChiaChi
Edwards, Christopher
Birbara, Charles
Mease, Philip
[J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1169 - 1169
[7] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials
Gladman, Dafna D.
Kavanaugh, Arthur
Adebajo, Adewale O.
Gomez-Reino, Juan J.
Wollenhaupt, Juergen
Cutolo, Maurizio
Schett, Georg A.
Lespessailles, Eric
McIlraith, Melissa
Hu, ChiaChi
Edwards, Christopher J.
Birbara, Charles A.
Mease, Philip J.
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[8] APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (52-WEEK) IMPROVEMENTS IN BASDAI IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS
Mease, P.
Marzo-Ortega, H.
Poder, A.
Van den Bosch, F.
Wollenhaupt, J.
Lespessailles, E.
McIlraith, M.
Teng, L.
Hall, S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 341 - 341
[9] APREMILAST, AN ORAL PHOSPHODIESTERASE-4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS
Gladman, Dafna D.
Kavanaugh, Arthur
Adebajo, Adewale O.
Gomez-Reino, Juan J.
Wollenhaupt, Juergen
Cutolo, Maurizio
Schett, Georg
Lespessailles, Eric
McIlraith, Melissa
Hu, ChiaChi
Edwards, Christopher J.
Birbara, Charles A.
Mease, Philip J.
[J]. RHEUMATOLOGY, 2016, 55 : 33 - 34
[10] APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III, RANDOMISED, CONTROLLED TRIALS
Dafna, Gladman
Stephen, Hall
Arthur, Kavanaugh
Adewale, Adebajo
Juan, Gomez-Reino
Jurgen, Wollenhaupt
Maurizio, Cutolo
Eric, Lespessailles
Melissa, Mcllraith
Chiachi, Hu
Christopher, Edwards
Charles, Birbara
Philip, Mease
[J]. INTERNAL MEDICINE JOURNAL, 2016, 46 : 22 - 23

← 1 2 3 4 5 →